Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Dual PPARalpha/PPARgamma agonists presented by Roche researchers

June 21, 2004

New bone or tissue-selective SARMs under study at Merck

June 21, 2004

Actelion and Celltech modify Zavesca license agreement

June 21, 2004

New indole-based androgenic agents covered by Akzo Nobel patent

June 18, 2004

Febuxostat reported to reduce serum urate levels of gout patients

June 18, 2004

New phase III hemodialysis trial for ferumoxytol iron replacement therapy

June 18, 2004

Novel fructose 1,6-bisphosphatase inhibitor lowers blood glucose in vivo

June 18, 2004

New antilipolytic agents targeting hRUP38 receptors

June 17, 2004

AstraZeneca presents novel PTP-1B inhibitors

June 17, 2004

FDA accepts IND for stem cell mobilizing drug CTCE-0214

June 17, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 22, 2026.
‘Detargeted’ targeted gene therapy improves activity in Pompe
BioWorld
A new strategy aims to improve gene therapy for Pompe disease by optimizing both the genetic component that restores the function of a deficient lysosomal enzyme...
Roche reports new TREM2 agonists
BioWorld Science
F. Hoffmann-la Roche Ltd. and Hoffmann-La Roche Inc. have identified new triggering receptor expressed on myeloid cells 2 (TREM2) agonists potentially useful for...
Genescience presents STAT6 degrader for atopic dermatitis
BioWorld Science
Genescience Pharmaceutical Co. Ltd. has presented data on a new STAT6 PROTAC degrader – GenSciP166 – which selectively targets STAT6 for proteasomal degradation....
Sangamo presents primate data for prion suppressor ST-506
BioWorld Science
Sangamo Therapeutics Inc. discussed gene regulation approaches for neurodegenerative diseases when presenting findings on their clinical candidate ST-506 for the...